Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.


Clinical Trial Description

Purpose: Opioid-related fatalities are a leading cause of death in Ohio and nationally, with an increasing number of overdoses attributable to fentanyl. Rapid fentanyl test strips (FTS) test for the presence of some types of fentanyl in urine samples and are increasingly being used to check illicit drugs for fentanyl before they are used. FTS use is a promising harm reduction strategy and research shows when people who use drugs (PWUD) receive a positive result, they are more likely to perform overdose risk reduction behaviors. However, access to FTS is limited, and there are barriers to the adoption of this intervention in some communities. This study will investigate FTS distribution and education as a harm reduction strategy to prevent overdoses among PWUD. Study findings will contribute valuable information about the feasibility and acceptability of integrating FTS drug checking into Project DAWN sites in rural and urban communities in Ohio and help us achieve our long-term goal of reducing overdose deaths. Study Design: Project DAWN sites that volunteer to participate in the study will be randomly assigned to either the intervention or non-intervention arm of the study. Clients in the intervention arm of the study will receive: - One-on-one education on the purpose, benefits, and limitations of FTS testing - A brief 20-minute fentanyl test strip educational intervention, including a 2-3-minute video and hands-on demonstrations on how to use FTS - A supply of FTS upon enrollment and throughout the 2-year follow up period Clients in the non-intervention arm of the study will receive: • FTS education and a supply of FTS will be offered to participants in the non-intervention arm in the last year of the study Consent: Written documentation of informed consent will be obtained from all participants. Incentives: Participants will be compensated for their time with a gift cards for completing the baseline survey, the survey at 6-months, and each biweekly survey. Recruitment and Retention: Having a close partnership with Project DAWN sites will help us recruit and retain study participants. In addition to key informant interviews in year one and questionnaires in year five, the research team will survey coordinators quarterly to collect data on Project DAWN site and coordinator experiences, identify concerns, and take corrective actions. The investigators will also maintain regular communication with Project DAWN site coordinators when the study staff are onsite. The research team will handle all enrollment of study clients, delivery of the FTS intervention, and follow up with study participants. Project DAWN sites will be asked to provide a small space for the research team to enroll participants and provide the FTS intervention (if applicable). The sites will also be asked to refer potentially eligible individuals to the research team at times when they are on-site. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05463341
Study type Interventional
Source Nationwide Children's Hospital
Contact Nichole Michaels, PhD
Phone 614-355-5870
Email nichole.michaels@nationwidechildrens.org
Status Recruiting
Phase N/A
Start date September 9, 2022
Completion date January 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT02425657 - Fast Track Module Based Colonoscopy Training Programme for Surgical Trainees at North Jutland Surgical Departments
Completed NCT04253158 - Implementation of a Web-based Alcohol and Other Drug Prevention Intervention for Collegiate Student-athletes N/A
Active, not recruiting NCT04700930 - CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia N/A
Recruiting NCT05994703 - Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine Phase 2
Completed NCT04210180 - Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction Phase 2/Phase 3
Recruiting NCT06115746 - A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students N/A
Recruiting NCT05493475 - Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants N/A
Terminated NCT03675503 - Reducing Hospital Falls by Empowering Nurses to Provide Ambulatory Aids N/A
Completed NCT01369693 - In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus Phase 1
Completed NCT01249339 - In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus Phase 1
Completed NCT01838473 - In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users Phase 1
Completed NCT04250727 - Switching to Potential Reduced Exposure Products in Adult Smokers N/A
Completed NCT04650269 - Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program Phase 4
Completed NCT04268173 - Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3 Phase 3
Not yet recruiting NCT04351958 - An Augmented Reality Videogame for Alcohol Use Prevention and Harm Reduction in Teens N/A
Active, not recruiting NCT05404815 - Exposure to Plasticisers in the Neonatal Intensive Care Unit
Not yet recruiting NCT06429436 - Vending Machine Naloxone Distribution for Your Community (VENDY) Phase 4
Not yet recruiting NCT06372899 - Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers N/A
Recruiting NCT05516069 - Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction. N/A
Completed NCT01130441 - Self-harming Behaviors Study of Adolescents in a Juvenile Detention House N/A